Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Thymic peptides are biologically active molecules derived from the thymus gland, with roles in immune system regulation. Their use in psoriasis is supported by some scientific investigation, although the evidence is limited and not robust. Psoriasis is an inflammatory, immune-mediated skin disorder, and thymic peptides have been studied for their immunomodulatory effects, aiming to restore immune balance. Small clinical studies and a few trials (such as those involving thymosin alpha-1 or thymomodulin) have reported improvements in psoriasis symptoms, including reduction in lesion severity and extent. These peptides are proposed to act by modulating T-cell activity, reducing pro-inflammatory cytokines, and promoting regulatory immune responses, which are all relevant to the pathogenesis of psoriasis. However, the majority of available studies are small, open-label, or lack rigorous controls, and systematic reviews highlight the need for larger, high-quality randomized controlled trials. Major dermatology guidelines do not currently recommend thymic peptides as a standard therapy for psoriasis, and their use remains experimental. In summary, there is a scientific rationale and some preliminary evidence for thymic peptides in psoriasis, but the strength of evidence is modest, warranting further research before widespread clinical adoption.

More about Thymic peptides
More about Psoriasis

Other ingredients used for Psoriasis

Other health conditions supported by Thymic peptides

Products containing Thymic peptides